Interactions between m6A modification and miRNAs in malignant tumors

Recently, the regulatory role of epigenetic modifications in the occurrence and development of malignant tumors has attracted extensive attention. RNA m6A methylation is the most abundant RNA modification in eukaryotic cells and regulates RNA transcription, processing, splicing, degradation, and translation. As important biomarkers, miRNAs play a crucial role in the diagnosis and treatment of diseases as well as in the development of anti-tumor drugs. Recently, increasing evidence has shown that m6A modification plays a vital role in regulating miRNA biosynthesis. We, herein, have reviewed the enzyme system involved in m6A methylation and the crosstalk between m6A modification and miRNAs in cancer. In addition, we have discussed the potential clinical applications and possible development directions of this field in the future.

Automated summary

The regulatory role of epigenetic modifications in malignant tumors has attracted extensive attention, with RNA m6A methylation being a crucial RNA modification. miRNAs are important biomarkers in disease diagnosis and treatment, with increasing evidence showing the vital role of m6A modification in regulating miRNA biosynthesis in cancer. The future potential clinical applications and development directions of this field have also been discussed.